EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

INFLUENCE OF SITAGLIPTIN ON PHARMACOKINETICS OF RALTEGRAVIR IN RATS

Dr. T. Lakshmi*

ABSTRACT

As antiretroviral therapy becomes increasingly accessible, the associated improvements in the health, quality of life and survival of patients. HIV infection and treatment has been associated with the development of insulin resistance, glucose intolerance and diabetes. The aim of the present study was to evaluate the effect of sitagliptin (antidiabetic drug) on pharmacokinetics of raltegravir (antiHIV drug) in rats. The pharmacokinetic parameters like t1/2, AUC, Clearance, Tmax and Cmax of raltegravir with and without combination of sitagliptin treatment was determined. The plasma concentration-time profiles of raltegravir following single dose and multiple dose treatment of sitagliptin were found to be dissimilar. There was change in the pharmacokinetic parameters in presence of sitagliptin indicates the significant (p>0.05) pharmacokinetic interaction.

Keywords: Raltegravir, sitagliptin, pharmacokinetics.

[Full Text Article] [Download Certificate]